RioTech Pharmaceuticals

About:

RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it.

Website: http://www.riotechpharma.com/

Top Investors: University Challenge Fund

Description:

RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it. Pharmasutical companies and reserchers from Oxford to California and all over the world are working to find better ways of treating and overcoming this virus. As it stands now, there is no here is no vaccine available to prevent HCV, and treatment for the stronger strain of the virus is only effective in treating it 50% of the time. However for those who are infected, there is some hope. Reserchers in the field of HCV treatment are beginging to understand more and more about Hepatitis C, and how to treat it. This website aims to relay this message to as many people as possible.

Total Funding Amount:

$1.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2003-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2005-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai